Key TakeawaysJohnson & Johnson on Wednesday proposed a settlement that would pay roughly $6.5 billion to settle lawsuits alleging the company's talc powder caused cancer.The settlement would resolve nearly all of the pending suits against J&J and its subsidiaries, the company said.Claimants would have three months to vote for or against the settlement package. Johnson & Johnson (JNJ) shares rose in early trading Wednesday after the company announced a plan that would resolve nearly all pending litigation ov ...

Johnson & Johnson (JNJ.N) announced on Wednesday a significant move towards resolving ongoing litigation over its baby powder and other talc products, with a proposed settlement amounting to $6.475 billion.Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.This substantial figure is aimed at settling tens of thousands of lawsuits alleging that the company’s talc products contain asbestos and could cause ovarian cancer. Johnson & Johnson plans settlement ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of ☑ 1934 for the quarterly period ended March 31, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission file number 1-3215 Johnson & Johnson (Exact name of registrant as specified in its charter) 22-1024240 New Jersey (State or other jurisdiction of (I.R.S. E ...

Exhibit 99.2 Johnson & Johnson and Subsidiaries Supplementary Sales Data (Unaudited; Dollars in Millions) FIRST QUARTER Percent Change 2024 2023 Total Operations Currency Sales to customers by geographic area U.S. $ 11,620 10,782 7.8% 7.8 — Europe 5,163 5,590 (7.6) (7.7) 0.1 Western Hemisphere excluding U.S. 1,194 1,076 11.0 21.3 (10.3) Asia-Pacific, Africa 3,406 3,446 (1.1) 5.0 (6.1) International 9,763 10,112 (3.4) (0.3) (3.1) Worldwide $ 21,383 20,894 2.3% 3.9 (1.6) Johnson & Johnson and Subsidiaries Sup ...

Johnson & Johnson baby powder is displayed in San Anselmo, California, on April 5, 2023.Johnson & Johnson on Wednesday said it will pay $6.5 billion to resolve nearly all lawsuits in the U.S. claiming its talc-based products caused ovarian cancer.This story is developing. Please check back for updates. ...

Key PointsThe first quarter of 2024 is coming to a wrap, showing investors where the most prominent Wall Street investors find opportunities to allocate funds. Three stocks became targets for investors like Buffett, Dalio, and Burry. Each has its own merit for being considered. Far from blindly following these pros, investors can see why these stocks are still potential additions in the coming cycle.5 stocks we like better than HSBCWhen the biggest names on Wall Street make an investment decision, the world ...

The healthcare behemoth has fortified its dividend.Johnson & Johnson (JNJ 0.43%) is arguably one of the safest dividend stocks in the world. The healthcare giant generates durable cash flow and has a fortress-like balance sheet. These features put its 3.4% yielding dividend on a rock-solid foundation.Here's why those seeking a bankable income stream should invest in Johnson & Johnson.Backed by the full faith and credit of Johnson & JohnsonJohnson & Johnson is one of only two companies in the world with a AA ...

These healthcare stocks can provide enviable long-term portfolio growth.The healthcare industry has proven to be particularly resilient to the ebb and tide of market sentiment through the years. While stock performance is individual to each company and its own unique growth story, there's a reason these businesses generally stay the course even when overall macro conditions are suffering.Broadly speaking, healthcare companies provide products and solutions that people need no matter what is happening with t ...

Is this top healthcare stock worth adding to your portfolio today?Johnson & Johnson (JNJ -0.46%) is an iconic name in healthcare, with a history that goes back to the 1800s. But in recent years it has faced some considerable challenges, namely to do with lawsuits and the legal battles it faces with respect to its talc products. And today it's a leaner company after having spun off its consumer health business.But the market still appears concerned -- shares of Johnson & Johnson are down 8% in the past 12 mo ...

PM Images The first quarter has come to a close! We are pumped up to share our March dividend income summary. My wife and I earned almost $5,000 in passive income this month. In this article, we will break down the dividend income received, the individual breakdown, and share how much of the income came from individual stocks and mutual funds or ETFs. Why I Invest in Dividend Stocks I invest in dividend stocks to grow my passive income with dividend income. One day, my dividend income will be large enough ...